Gibson Laboratories LLC recalls Blastomyces dermatitidis Antiserum 1 mL vial GIBSON BIOSCIENCE. Catalog 200265 Intended for identification of the syste…
- Recall date
- January 20, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0606-2018
- FDA classification
- Class II
- Brand / firm
- Gibson Laboratories LLC
- Sold / distributed
- Distributed to the states of AL, AZ & MS.
Why it was recalled
The firm information that the product was reporting false positive results
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Blastomyces dermatitidis Antiserum 1 mL vial GIBSON BIOSCIENCE. Catalog 200265 Intended for identification of the systemic fungal pathogens.
Get recall alerts
Free email alert whenever Gibson Laboratories LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Gibson Laboratories LLC